Additional work is needed to elucidate how the overexpression of sFRP4 contributes to the ability of progesterone to promote leiomyoma growth and determine how its distinct pattern of regulation contributes to uterine smooth muscle tumorigenesis. The gene discussed is SFRP4; the disease is leiomyoma.